Goonawardane Niluka, Gebhardt Anna, Bartlett Christopher, Pichlmair Andreas, Harris Mark
School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.
Max Planck Institute of Biochemistry, Martinsried, Germany.
J Virol. 2017 Aug 10;91(17). doi: 10.1128/JVI.00805-17. Print 2017 Sep 1.
Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is a phosphoprotein that plays key, yet poorly defined, roles in both virus genome replication and virion assembly/release. It has been proposed that differential phosphorylation could act as a switch to regulate the various functions of NS5A; however, the mechanistic details of the role of this posttranslational modification in the virus life cycle remain obscure. We previously reported (D. Ross-Thriepland, J. Mankouri, and M. Harris, J Virol 89:3123-3135, 2015, doi:10.1128/JVI.02995-14) a role for phosphorylation at serine 225 (S225) of NS5A in the regulation of JFH-1 (genotype 2a) genome replication. A phosphoablatant (S225A) mutation resulted in a 10-fold reduction in replication and a perinuclear restricted distribution of NS5A, whereas the corresponding phosphomimetic mutation (S225D) had no phenotype. To determine the molecular mechanisms underpinning this phenotype we conducted a label-free proteomics approach to identify cellular NS5A interaction partners. This analysis revealed that the S225A mutation disrupted the interactions of NS5A with a number of cellular proteins, in particular the nucleosome assembly protein 1-like protein 1 (NAP1L1), bridging integrator 1 (Bin1, also known as amphiphysin II), and vesicle-associated membrane protein-associated protein A (VAP-A). These interactions were validated by immunoprecipitation/Western blotting, immunofluorescence, and proximity ligation assay. Importantly, small interfering RNA (siRNA)-mediated knockdown of NAP1L1, Bin1 or VAP-A impaired viral genome replication and recapitulated the perinuclear redistribution of NS5A seen in the S225A mutant. These results demonstrate that S225 phosphorylation regulates the interactions of NS5A with a defined subset of cellular proteins. Furthermore, these interactions regulate both HCV genome replication and the subcellular localization of replication complexes. Hepatitis C virus is an important human pathogen. The viral nonstructural 5A protein (NS5A) is the target for new antiviral drugs. NS5A has multiple functions during the virus life cycle, but the biochemical details of these roles remain obscure. NS5A is known to be phosphorylated by cellular protein kinases, and in this study, we set out to determine whether this modification is required for the binding of NS5A to other cellular proteins. We identified 3 such proteins and show that they interacted only with NS5A that was phosphorylated on a specific residue. Furthermore, these proteins were required for efficient virus replication and the ability of NS5A to spread throughout the cytoplasm of the cell. Our results help to define the function of NS5A and may contribute to an understanding of the mode of action of the highly potent antiviral drugs that are targeted to NS5A.
丙型肝炎病毒(HCV)非结构蛋白5A(NS5A)是一种磷蛋白,在病毒基因组复制以及病毒粒子组装/释放过程中发挥着关键作用,但其作用机制尚不明确。有人提出,差异磷酸化可能作为一种开关来调节NS5A的各种功能;然而,这种翻译后修饰在病毒生命周期中的作用的机制细节仍不清楚。我们之前报道过(D. Ross-Thriepland、J. Mankouri和M. Harris,《病毒学杂志》89:3123 - 3135,2015年,doi:10.1128/JVI.02995 - 14)NS5A丝氨酸225(S225)位点的磷酸化在调节JFH - 1(2a基因型)基因组复制中的作用。一种磷酸化消除突变(S225A)导致复制减少10倍,并使NS5A呈核周受限分布,而相应的模拟磷酸化突变(S225D)则没有表型。为了确定这种表型背后的分子机制,我们采用了一种无标记蛋白质组学方法来鉴定细胞内NS5A的相互作用伙伴。该分析表明,S225A突变破坏了NS5A与多种细胞蛋白的相互作用,特别是核小体组装蛋白1样蛋白1(NAP1L1)、桥连整合因子1(Bin1,也称为 amphiphysin II)和囊泡相关膜蛋白相关蛋白A(VAP - A)。这些相互作用通过免疫沉淀/蛋白质印迹、免疫荧光和邻近连接分析得到了验证。重要的是,小干扰RNA(siRNA)介导的NAP1L1、Bin1或VAP - A敲低会损害病毒基因组复制,并重现了S225A突变体中NS5A的核周重新分布。这些结果表明,S225磷酸化调节NS5A与特定细胞蛋白子集的相互作用。此外,这些相互作用调节HCV基因组复制以及复制复合物的亚细胞定位。丙型肝炎病毒是一种重要的人类病原体。病毒非结构5A蛋白(NS5A)是新型抗病毒药物的靶点。NS5A在病毒生命周期中具有多种功能,但其这些作用的生化细节仍不清楚。已知NS5A被细胞蛋白激酶磷酸化,在本研究中,我们着手确定这种修饰对于NS5A与其他细胞蛋白结合是否必需。我们鉴定出了3种这样的蛋白,并表明它们仅与在特定残基上被磷酸化的NS5A相互作用。此外,这些蛋白对于有效的病毒复制以及NS5A在细胞胞质中扩散的能力是必需的。我们的结果有助于明确NS5A的功能,并可能有助于理解针对NS5A的高效抗病毒药物的作用模式。